Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Strategic review this thing

<< Previous

Bullboard Posts

Next >>

Comment by PinnacleXon Jul 21, 2023 2:01pm

94 Views

Post# 35551898

RE:Strategic review this thing

What are you going on about now $2 you're stuck on this $2 it's gonna fall until it's 50 or 40 cents and then it's gonna be broken down for pennies on a dollar, this is how it works if your new to the stock market educate yourself,this is exactly what's going to happen.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?